Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 18 (Search time: 0.0 seconds).
Item hits:
Issue DateTitleAuthor(s)
Jun-2019Clozapine-induced pericarditis: an ethical dilemmaJohal, Harleen Kaur; Barrera, Alvaro
Oct-2019Comparative effects of 18 antipsychotics on metabolic function in schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysisCipriani, Andrea
Jul-2020Clinicians’ views of treatment types for first episode psychosis delivered in a randomised controlled trial (MAPS)Bird, Jessica C.
Jul-2020Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility studyJohns, Louise; Freeman, Daniel; Broome, Matthew R.; James, Anthony
Jan-2020The side effect profile of Clozapine in real world data of three large mental hospitalsSmith, Tanya
Jul-2020Understanding young peoples’ and family members’ views of treatment for first episode psychosis in a randomised controlled trial (MAPS)Bird, Jessica C.
Jan-2021Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCTBroome, Matthew R.; Freeman, Daniel; Johns, Louise; James, Anthony; Maughan, Daniel L
Aug-2021How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size IndicesCipriani, Andrea
Jul-2019Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)Broome, Matthew R.; Freeman, Daniel
Feb-2022Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical TrialsCipriani, Andrea; Tomlinson, Anneka